Literature DB >> 29107455

Type 2 diabetes mellitus and risk of open-angle glaucoma development in Koreans: An 11-year nationwide propensity-score-matched study.

Y Jung1, K Han2, H-Y L Park1, C K Park3.   

Abstract

PURPOSE: To evaluate the risk of primary open-angle glaucoma (POAG) development in type 2 diabetes mellitus (T2DM) patients.
METHODS: In this 11-year longitudinal study based on the Korean National Health Insurance research database, the data collected comprised 1,025,340 (2.2%) participants who were randomly selected from 46,605,433 Korean residents in 2002. The database was analyzed to identify participants with an initial diagnosis of T2DM in 2003-2004. The control group was composed of participants without T2DM who were propensity-score-matched, five controls per T2DM patient, according to age, gender, household income, residential area and underlying diseases, including hypertension, dyslipidaemia, coronary heart disease, cerebrovascular disease and thyroid disease. Cox proportional-hazards regression was used to calculate the overall hazard ratios (HRs) in participants with and without T2DM for development of POAG before and after adjusting for confounding factors.
RESULTS: There were 12,657 participants with T2DM and 63,285 propensity-score-matched controls without T2DM. POAG developed in 413 (3.3%) and 1188 (1.9%) participants in the T2DM and control groups, respectively. T2DM was associated with an increased risk of POAG development [HR: 1.80; 95% confidence interval (CI): 1.58-2.04] after adjusting for age, gender, household income and other potential confounders.
CONCLUSION: T2DM was significantly associated with the development of POAG after adjusting for potential confounders in the Korean population.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Primary open-angle glaucoma; Type 2 diabetes mellitus

Mesh:

Year:  2017        PMID: 29107455     DOI: 10.1016/j.diabet.2017.09.007

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  8 in total

1.  Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma.

Authors:  Jacob Sterling; Peiying Hua; Joshua L Dunaief; Qi N Cui; Brian L VanderBeek
Journal:  Br J Ophthalmol       Date:  2021-08-19       Impact factor: 4.638

Review 2.  Association Between Diabetes, Diabetic Retinopathy, and Glaucoma.

Authors:  Yangjiani Li; William Mitchell; Tobias Elze; Nazlee Zebardast
Journal:  Curr Diab Rep       Date:  2021-09-08       Impact factor: 5.430

3.  Type 2 Diabetes, Fasting Glucose, Hemoglobin A1c Levels and Risk of Primary Open-Angle Glaucoma: A Mendelian Randomization Study.

Authors:  Zhao Hu; Feixiang Zhou; Atipatsa Chiwanda Kaminga; Huilan Xu
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-05-02       Impact factor: 4.925

Review 4.  Community care for diabetic retinopathy and glaucoma in India: A panel discussion.

Authors:  Padmaja Kumari Rani; Vinay Nangia; Krishna R Murthy; Rohit C Khanna; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

5.  Relationship between Using Fibrate and Open-Angle Glaucoma in Hyperlipidemic Patients: A Population-Based Cohort Study.

Authors:  Yung-En Tsai; Yi-Hao Chen; Chien-An Sun; Chi-Hsiang Chung; Wu-Chien Chien; Ke-Hung Chien
Journal:  Int J Environ Res Public Health       Date:  2022-02-19       Impact factor: 3.390

Review 6.  Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma?

Authors:  Zaynab Ahmad Mouhammad; Rupali Vohra; Anna Horwitz; Anna-Sophie Thein; Jens Rovelt; Barbara Cvenkel; Pete A Williams; Augusto Azuara-Blanco; Miriam Kolko
Journal:  Front Neurosci       Date:  2022-02-21       Impact factor: 4.677

7.  Development of Open-Angle Glaucoma in Adults With Seropositive Rheumatoid Arthritis in Korea.

Authors:  Seung Hoon Kim; Sung Hoon Jeong; Hyunkyu Kim; Eun-Cheol Park; Suk-Yong Jang
Journal:  JAMA Netw Open       Date:  2022-03-01

8.  Diabetes mellitus and incident glaucoma in Australia: a 10-year cohort study from the 45 and Up Study.

Authors:  Yu Jiang; Guobei Xiao; Xiaotong Han; Zhuoting Zhu; Xianwen Shang; Ruilin Xiong; Jane Scheetz; Lei Zhang; Katerina V Kiburg; Mingguang He
Journal:  Ann Transl Med       Date:  2022-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.